¿Se ha incrementado el uso de bloqueadores beta en pacientes con insuficiencia cardiaca en medicina interna? Implicaciones pronósticas: registro RICA

González-García, Andrés; Montero Pérez-Barquero, Manuel; Formiga, Francesc; González-Juanatey, José R; Quesada, M Angustias; Epelde, Francisco; Oropesa, Roberto; Díez-Manglano, Jesús; Cerqueiro, José M; Manzano, Luis.
Rev. esp. cardiol. (Ed. impr.) ; 67(3): 196-202, mar. 2014. graf, tab
Artículo en Español | IBECS (España) | ID: ibc-119984

Documentos relacionados

  1. Beta-blocker efficacy across different cardiovascular indications: an umbrella review and meta-analytic assessment.
  2. Beta-blocker therapy in patients with COPD: a systematic literature review and meta-analysis with multiple treatment comparison.
  3. Long-Term Beta-Blocker Therapy After Myocardial Infarction Without Heart Failure in the Reperfusion Era-Systemic Review and Meta-analysis.
  4. [Frequency of use and Indications for Beta-Blockers in Heart Failure with Preserved Ejection Fraction].
  5. Quantifying the benefit of nonselective beta-blockers in the prevention of hepatic decompensation: A Bayesian reanalysis of the PREDESCI trial.
  6. Can the hemodynamic model in heart failure be restored based on analysis of ventricular-arterial coupling?
  7. Right Ventricular Ejection Fraction and Beta-Blocker Effect in Heart Failure With Reduced Ejection Fraction.
  8. Effect of Premorbid Beta-Blockers on Mortality in Patients With Sepsis: A Systematic Review and Meta-Analysis.
  9. Association of preoperative beta-blocker use and cardiac complications after major noncardiac surgery: a prospective cohort study.
  10. Does Heterogeneity Exist in Treatment Associations With Renin-Angiotensin-System Inhibitors or Beta-blockers According to Phenotype Clusters in Heart Failure with Preserved Ejection Fraction?